Press release
Biliary Tract Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis, DelveInsight | Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC Zho
Biliary Tract Cancer Pipeline Insights
Biliary Tract Cancer Overview:
Biliary tract cancer is a type of cancer that develops in the cells of the bile ducts, gallbladder, or ampulla of Vater. When it occurs in the bile ducts, it is known as cholangiocarcinoma, and it is classified based on the location of the cancer: intrahepatic (within the liver), hilar (where the left and right hepatic ducts meet), and extrahepatic (outside the liver, affecting the common bile duct). Each type has distinct genetic factors, risk factors, and clinical features. Diagnosis typically involves ultrasound, CT scans, MRI, and MRCP (magnetic resonance cholangiopancreatography). The only curative treatment is surgery to remove the tumor, though recurrence is common. Chemotherapy and radiotherapy are used as adjunct therapies. Ongoing research into targeted therapies and immunotherapies, particularly in adjuvant and neoadjuvant settings, along with molecular studies, is expected to improve survival and quality of life for patients with this disease.
Request for a detailed insights report on Biliary Tract Cancer pipeline insights @ https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
"Biliary Tract Cancer Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Biliary Tract Cancer Therapeutics Market.
Key Takeaways from the Biliary Tract Cancer Pipeline Report
DelveInsight's Biliary Tract Cancer pipeline report depicts a robust space with 80+ active players working to develop 80+ pipeline therapies for Biliary Tract Cancer treatment.
In November 2024, Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for Ziihera® (zanidatamab-hrii) 50mg/mL intravenous injection to treat adults with previously treated, unresectable, or metastatic HER2-positive (IHC 3+) biliary tract cancer (BTC), identified through an FDA-approved test. Ziihera received this approval based on a 52% objective response rate (ORR) and a median duration of response (DOR) of 14.9 months, as assessed by independent central review. Continued approval may depend on confirming clinical benefit in a follow-up trial. The Phase 3 HERIZON-BTC-302 trial is ongoing to assess zanidatamab in combination with standard therapy versus standard therapy alone in first-line treatment of HER2-positive BTC.
In August 2024, Compass Therapeutics, Inc. announced the completion of patient enrollment in its COMPANION-002 trial. This randomized Phase 2/3 study, involving 150 patients, evaluates CTX-009 in individuals with biliary tract cancer (BTC).
In June 2024, Bold Therapeutics shared positive Phase 2 safety and efficacy results for its lead treatment, BOLD-100, for advanced metastatic biliary tract cancer (BTC) and gastric cancer (GC) at the American Society of Clinical Oncology (ASCO) annual meeting.
Key Biliary Tract Cancer companies such as Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee's Pharmaceutical Limited, Hoffmann-La Roche, Shanghai Miracogen Inc., Zymeworks Inc., Bristol-Myers Squibb, Eli Lilly and Company, Ipsen, Threshold Pharmaceuticals, Leap Therapeutics, Hutchison Medipharma Limited, Array BioPharma, Redx Pharma Plc, Compass Therapeutics, Lee's Pharmaceutical Limited, and others are evaluating new drugs for Biliary Tract Cancer to improve the treatment landscape.
Promising Biliary Tract Cancer pipeline therapies in various stages of development include MRG 002, Disitamab vedotin, Envafolimab, DKN-01, and others.
Biliary Tract Cancer Pipeline Analysis
The report provides insights into:
The report provides detailed insights into the key companies that are developing therapies in the Biliary Tract Cancer Market.
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Biliary Tract Cancer treatment.
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Biliary Tract Cancer market.
Download our free sample page report on Biliary Tract Cancer pipeline insights @ https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Biliary Tract Cancer Emerging Drugs
MRG 002: Miracogen
Disitamab vedotin: Yantai Rongchang Pharmaceutical
Envafolimab: Alphamab Oncology
DKN-01: Leap Therapeutics
Biliary Tract Cancer Companies
Over 80 key companies are working on developing therapies for biliary tract cancer. Among them, SMT Bio Co., Ltd. has drug candidates for biliary tract cancer in the advanced Phase II/III stage.
DelveInsight's report covers around 80+ products under different phases of clinical development like
Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Biliary Tract Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
Intravenous
Subcutaneous
Oral
Intramuscular
Biliary Tract Cancer Products have been categorized under various Molecule types such as
Monoclonal antibody
Small molecule
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Biliary Tract Cancer Therapies and Key Companies: Biliary Tract Cancer Clinical Trials and advancements @ https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Biliary Tract Cancer Pipeline Therapeutic Assessment
• Biliary Tract Cancer Assessment by Product Type
• Biliary Tract Cancer By Stage
• Biliary Tract Cancer Assessment by Route of Administration
• Biliary Tract Cancer Assessment by Molecule Type
Download Biliary Tract Cancer Sample report to know in detail about the Biliary Tract Cancer treatment market @ Biliary Tract Cancer Therapeutic Assessment @ https://www.delveinsight.com/sample-request/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Biliary Tract Cancer Current Treatment Patterns
4. Biliary Tract Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Biliary Tract Cancer Late-Stage Products (Phase-III)
7. Biliary Tract Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Biliary Tract Cancer Discontinued Products
13. Biliary Tract Cancer Product Profiles
14. Biliary Tract Cancer Key Companies
15. Biliary Tract Cancer Key Products
16. Dormant and Discontinued Products
17. Biliary Tract Cancer Unmet Needs
18. Biliary Tract Cancer Future Perspectives
19. Biliary Tract Cancer Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Biliary Tract Cancer Pipeline Reports Offerings: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Contact Info:
Kritika Rehani
krehani@delveinsight.com
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biliary Tract Cancer Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis, DelveInsight | Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC Zho here
News-ID: 3818757 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Biliary
Global Metal Pancreatic Biliary Stent Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Metal Pancreatic Biliary Stent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The metal pancreatic biliary stent market is witnessing consistent growth due to the rising prevalence of…
Major Market Share Shift in Biliary Catheters Industry: Advancements In Biliary …
What Is the Forecasted Market Size and Growth Rate for the Biliary Catheters Market?
The market size for biliary catheters has experienced robust growth in recent years. There is an expected growth from $3.42 billion in 2024 to $3.75 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 9.7%. Factors like increased occurrences of biliary tract ailments, the popularity of minimally invasive procedures, a growing aging population, more…
Primary Biliary Cholangitis Treatment Market
Primary Biliary Cholangitis Treatment Market
Global Primary Biliary Cholangitis Treatment Market Expected to Reach US$ YY Million by 2030, Growing at a CAGR of YY%: Market Insights and Dynamics
The Global Primary Biliary Cholangitis Treatment Market, which reached US$ YY billion in 2022, is anticipated to achieve US$ YY million by 2030, exhibiting a robust CAGR of YY% during the forecast period from 2024 to 2031.
Primary Biliary Cholangitis (PBC), formerly known as…
Biliary Stents Market - Unleashing Flow: Empowering Biliary Health with Innovati …
Newark, New Castle, USA - new report, titled Biliary Stents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Biliary Stents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Biliary Stents market. The report offers an overview of the market, which…
High Prevalence of Biliary Diseases Across the Globe is Driving the Biliary Sten …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
Rise in Surgical Procedures of Biliary Diseases is Expected to Boost the Biliary …
Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid.…
